Ireland
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 109.32 B |
Jan. 14, 2025 | USD 85.25 | 4.23% |
|
Ireland |
|
2 |
USD 38.60 B |
Jan. 14, 2025 | USD 42.18 | 0.76% |
|
Ireland |
|
3 |
USD 20.49 B |
Jan. 14, 2025 | USD 207.57 | 0.10% |
|
Ireland |
|
4 |
USD 16.53 B |
Jan. 14, 2025 | USD 200.24 | -8.14% |
|
Ireland |
|
5 |
USD 15.63 B |
Jan. 14, 2025 | USD 93.99 | 0.60% |
|
Ireland |
|
6 |
USD 7.43 B |
Jan. 14, 2025 | USD 122.96 | -0.16% |
|
Ireland |
|
7 |
USD 4.61 B |
Jan. 14, 2025 | USD 28.50 | 0.53% |
|
Ireland |
|
8 |
USD 1.02 B |
Jan. 13, 2025 | USD 69.11 | -2.10% |
|
Ireland |
|
9 |
USD 775.71 M |
Jan. 14, 2025 | USD 8.05 | 2.94% |
|
Ireland |
|
10 |
USD 681.76 M |
Jan. 14, 2025 | USD 12.67 | -3.50% |
|
Ireland |
|
11 |
USD 559.93 M |
Jan. 14, 2025 | USD 2.05 | 2.67% |
|
Ireland |
|
12 |
USD 426.11 M |
Jan. 14, 2025 | USD 8.19 | -1.92% |
|
Ireland |
|
13 |
USD 171.82 M |
Jan. 14, 2025 | USD 9.02 | 1.18% |
|
Ireland |
|
14 |
USD 63.46 M |
Jan. 14, 2025 | USD 3.72 | -0.53% |
|
Ireland |
|
15 |
USD 44.03 M |
Jan. 14, 2025 | USD 1.60 | -2.44% |
|
Ireland |
|
16 |
USD 1.68 M |
Jan. 14, 2025 | USD 0.02 | -6.17% |
|
Ireland |
The Pharmaceuticals company in Ireland with the highest Market Capitalization is Medtronic plc (NYSE: MDT) at USD 109.32 B.
The Pharmaceuticals company in Ireland with the lowest Market Capitalization is Ovoca Bio plc (LSE: OVB.L) at USD 1.68 M.
The top 10 Pharmaceuticals companies in Ireland by Market Capitalization are Medtronic plc, Experian plc, STERIS plc, ICON Public Limited Company, Kerry Group plc, Jazz Pharmaceuticals plc, Alkermes plc, Cosmo Pharmaceuticals N.V., Avadel Pharmaceuticals plc and Prothena Corporation plc.
The bottom 10 Pharmaceuticals companies in Ireland by Market Capitalization are Ovoca Bio plc, Iterum Therapeutics plc, Mural Oncology plc, Malin Corporation plc, GH Research PLC, Uniphar plc, Prothena Corporation plc, Avadel Pharmaceuticals plc, Cosmo Pharmaceuticals N.V. and Alkermes plc.